Goldman Sachs Starts Precision BioSciences Inc. (DTIL) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Jefferies Starts Precision BioSciences Inc. (DTIL) at Buy
April 22, 2019 6:42 AM EDTJefferies analyst Maury Raycroft initiates coverage on Precision BioSciences Inc. (NASDAQ: DTIL) with a Buy rating and a price target of $25.00.
For an analyst ratings summary and ratings history on Precision BioSciences Inc.... More
JPMorgan Starts Precision BioSciences Inc. (DTIL) at Overweight
April 22, 2019 1:41 AM EDTJPMorgan analyst Eric Joseph initiates coverage on Precision BioSciences Inc. (NASDAQ: DTIL) with a Overweight rating and a price target of $23.00.
Favors the company's competitive positioning in the manufacture of off-the0-shelf CAR Ts which is likely the next... MoreBarclays Starts Precision BioSciences Inc. (DTIL) at Overweight
April 22, 2019 12:45 AM EDTBarclays analyst Gena Wang initiates coverage on Precision BioSciences Inc. (NASDAQ: DTIL) with a Overweight rating and a price target of $24.00.
Believes the company's proprietary ARCUS genome-editing platform possesses unique advantages with editing efficiency largely comparable to other gene editing... More